id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-5319-0016,FDA,FDA-2017-N-5319,"Notice of Followup to Notice of Public Hearing and Request for Comments on Devices Proposed for a New Use With an Approved, Marketed Drug",Notice,Announcement,2020-05-08T04:00:00Z,2020,5,2020-05-08T04:00:00Z,,2020-05-08T12:48:24Z,2020-09832,0,0,09000064845858f0
FDA-2017-N-5319-0008,FDA,FDA-2017-N-5319,Transcript Part 15 Hearing Devices Referencing Drugs to Dockets Management,Other,Transcript(s),2018-01-26T05:00:00Z,2018,1,2018-01-26T05:00:00Z,,2018-01-26T18:58:40Z,,0,0,0900006482e6ddcc
FDA-2017-N-5319-0007,FDA,FDA-2017-N-5319,"Devices Proposed for a New Use With an Approved, Marketed Drug; Public Hearing; Reopening of the Comment Period",Proposed Rule,Extension of Comment Period,2018-01-22T05:00:00Z,2018,1,2018-01-22T05:00:00Z,2018-02-22T04:59:59Z,2018-02-24T02:01:42Z,2018-00991,0,0,0900006482e3eea7
FDA-2017-N-5319-0001,FDA,FDA-2017-N-5319,"Devices Proposed for a New Use With an Approved, Marketed Drug; Public
Hearing; Request for Comments",Notice,Request for Comments,2017-09-26T04:00:00Z,2017,9,2017-09-26T04:00:00Z,2018-01-16T04:59:59Z,2018-01-18T02:04:03Z,2017-20521,0,0,0900006482b7ba3e